CRX is an intrinsic suppressor of epithelial‒mesenchymal transition in retinal pigment epithelial cells: a promising therapeutic avenue for subretinal fibrosis

Dongli Li, Qingjian Ou, Furong Gao, Xi Wang, Lilin Zhu, Ye Zhou, Jing-Ying Xu, Caixia Jin, Juan Wang, Jieping Zhang, Jiao Li, Yanlong Bi, Lixia Lu, Guo-Tong Xu, Haibin Tian · 2025

Read CRX is an intrinsic suppressor of epithelial‒mesenchymal transition in retinal pigment epithelial cells: a promising therapeutic avenue for subretinal fibrosis by Dongli Li, Qingjian Ou, Furong Gao, Xi Wang, Lilin Zhu, Ye Zhou, Jing-Ying Xu, Caixia Jin, Juan Wang, Jieping Zhang, Jiao Li, Yanlong Bi, Lixia Lu, Guo-Tong Xu, Haibin Tian (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12859066.txt.

Description

Dongli Li and co-authors find a built-in brake on a harmful cell change in the eye's pigment layer, in work from 2025. That change helps drive scar tissue under the retina in age-related macular degeneration. Many paths that push the change were known, but paths that hold it back inside the cells were not.

The brake is a protein called CRX, best known from light-sensing cells. Two signal paths together switch CRX off by moving a partner protein into the nucleus. Restoring CRX blocked the harmful change in lab-grown pigment cells, partly through a second protein it raises. Tests in a mouse eye model backed the effect. The authors propose CRX as a drug target.

Catalog record

CREATORDongli Li, Qingjian Ou, Furong Gao, Xi Wang, Lilin Zhu, Ye Zhou, Jing-Ying Xu, Caixia Jin, Juan Wang, Jieping Zhang, Jiao Li, Yanlong Bi, Lixia Lu, Guo-Tong Xu, Haibin Tian
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12859066

Browse the full library · About the Tower of Babel